Crestline Management’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,000
Closed -$251K 232
2022
Q4
$251K Buy
+25,000
New +$248K 0.04% 153

Other funds holding AONC

Crestline Management's AONC Position: Q1 2023 in Review

Crestline Management sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 25,000 shares — an estimated $251K sold.

Crestline Management first reported a position in AONC in Q4 2022 and held it in 1 quarter. The position peaked at $251K in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.

  • Crestline Management reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Crestline Management sold 25,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $251K.
  • Crestline Management first reported a position in American Oncology Network, Inc. Class A Common Stock in Q4 2022 and held it in 1 quarter.
  • Crestline Management's American Oncology Network, Inc. Class A Common Stock position peaked at $251K in Q4 2022.
  • 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.

Based on Crestline Management's 13F filing for Q1 2023, filed 15 May 2023.